Product Launches and Approvals
Nerve repair and regeneration offers products such as neuromodulators, neurostimulation, and biomaterial devices. These devices are utilized for the treatment of neurodegenerative or traumatic disorders such as Parkinson's disease, Alzheimer's disease, sclerosis, multiple system atrophy, and amyotrophic lateral sclerosis. Therefore, market players are launching various products such as internal neurostimulation devices, external neurostimulation devices, nerve conduits, nerve wraps, nerve connectors, and other biomaterials enhance the treatment output of nerve repair and regeneration. A few of the recent developments related to the nerve repair and regeneration market are In July 2022, Checkpoint Surgical launched the Checkpoint Edge Nerve Cutting Kit, expanding the strength of the intraoperative nerve care portfolio of the company. The Checkpoint Edge Nerve Cutting Kit is the first offering in the planned portfolio of nerve-specific instruments by Checkpoint Surgical, with further expansion planned in the future.
Similarly, In Mar-2022: Integra LifeSciences Holding Corporation launched the NeuraGen 3D Nerve Guide Matrix, which is a resorbable implant for the repair of peripheral nerve discontinuities. NeuraGen 3D is a nerve repair product specifically engineered to develop an optimized environment that enables a greater complete functional recovery following mid-gap nerve repair in comparison to hollow nerve conduits alone. Further, In Aug 2021, Checkpoint Surgical, Inc. launched the NeuroShield Chitosan Nerve Wrap to expand its intraoperative nerve care product line. The NeuroShield Wrap marks is the first product in a planned line of chitosan-based biological implants of the company to support nerve healing. Adding the product, complements the existing product portfolio of Checkpoint Surgical, including the company’s flagship Checkpoint Nerve Stimulator/Locator, the leading nerve stimulation device for intraoperative nerve protection and repair. Thus, the active participation of market players in product innovation and development and increase in approvals of products are likely to fuel the market growth in the coming years.
Market Overview
The Middle East & Africa nerve repair & regeneration market is segmented into the UAE, Saudi Arabia, South Africa, and the Rest of Middle East & Africa. The growing prevalence of neurological disorders and a surge in research and development activities are driving the growth of the nerve repair & regeneration market. According to WHO, ~80% of strokes are expected to occur in low- and middle-income countries. According to Alzheimer’s disease International, the number of people having Alzheimer’s disease is expected to reach 131.5 million by 2050 in low-and middle-income countries. As per the American Academy of Neurology, in 2022, ~17.6 million (11.7%) DALYs were reported in the region. In the UAE, stroke and dementia are the leading causes of disability-adjusted life years (DALYs) and death. According to WHO, in 2020, in the UAE, ~0.51% of total deaths were due to Parkinson’s disease. The growing geriatric population is significantly increasing the prevalence of Alzheimer’s disease. Thus, the increasing prevalence of neurological diseases among the geriatric population of the UAE is driving the growth of the nerve repair & regeneration market.
Middle East & Africa Nerve Repair & Regeneration Market Revenue and Forecast to 2028 (US$ Million)
Strategic insights for the Middle East & Africa Nerve Repair & Regeneration provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market. The geographic scope of the Middle East & Africa Nerve Repair & Regeneration refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.Middle East & Africa Nerve Repair & Regeneration Strategic Insights
Middle East & Africa Nerve Repair & Regeneration Report Scope
Report Attribute
Details
Market size in 2022
US$ 300.76 Million
Market Size by 2028
US$ 494.31 Million
Global CAGR (2022 - 2028)
8.6%
Historical Data
2020-2021
Forecast period
2023-2028
Segments Covered
By Product
By Application
Regions and Countries Covered
Middle East and Africa
Market leaders and key company profiles
Middle East & Africa Nerve Repair & Regeneration Regional Insights
Middle East & Africa Nerve Repair & Regeneration Market Segmentation
The Middle East & Africa nerve repair & regeneration market is segmented into product, application, and country.
Based on simulator type, the market is segmented into neurostimulation and neuromodulation devices and biomaterials. The neurostimulation and neuromodulation devices segment registered the largest market share in 2022.
Based on application, the market is categorized into neurostimulation & neuromodulation applications and nerve repair & regeneration applications. The nerve repair & regeneration applications segment held the largest market share in 2022.
Based on country, the Middle East & Africa nerve repair & regeneration market is segmented into Saudi Arabia, South Africa, the UAE, and the Rest of MEA. Further, the Rest of MEA dominated the market in 2022.
Axogen Corporation, Boston Scientific Corporation, Integra LifeSciences, Medtronic, Abbott Laboratories, Stryker Corporation, Neuronetics, LivaNova PLC, Baxter, and Polyganics BV are the leading companies operating in the nerve repair & regeneration market in the Middle East & Africa.
The Middle East & Africa Nerve Repair & Regeneration Market is valued at US$ 300.76 Million in 2022, it is projected to reach US$ 494.31 Million by 2028.
As per our report Middle East & Africa Nerve Repair & Regeneration Market, the market size is valued at US$ 300.76 Million in 2022, projecting it to reach US$ 494.31 Million by 2028. This translates to a CAGR of approximately 8.6% during the forecast period.
The Middle East & Africa Nerve Repair & Regeneration Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Middle East & Africa Nerve Repair & Regeneration Market report:
The Middle East & Africa Nerve Repair & Regeneration Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Middle East & Africa Nerve Repair & Regeneration Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Middle East & Africa Nerve Repair & Regeneration Market value chain can benefit from the information contained in a comprehensive market report.